New Drug Candidate Blocks Resistance to Cancer Therapies
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation of the inhibitor, MTX-531...
25-Jul-2024 10:05 AM EDT
Add to Favorites